Navigation Links
Microwave treatments for enlarged prostate cause blood pressure surges
Date:4/8/2008

ROCHESTER, Minn. -- Many men who receive microwave therapy for enlarged prostates experience significant surges in blood pressure that could raise their risk of a heart attack or stroke, according to new research findings published recently in Mayo Clinic Proceedings.

The Mayo Clinic-led study of 185 consecutive patients who received transurethral microwave therapy at four medical centers found that 42 percent experienced systolic blood pressure surges of more than 30 mm Hg, while 5 percent had surges of more than 70 mm Hg.

Men who are candidates for this minimally invasive microwave therapy tend also to be at higher risk for cardiac events, says Lance Mynderse, M.D., the Mayo Clinic urologist who authored the study. Blood pressure surges of the magnitude identified in this study are troubling side effects of treatment that need to be monitored and managed.

Benign prostatic hyperplasia (BPH), or an enlarged prostate gland, is a condition affecting half of men over age 50 and 80 percent of those over 70. Symptoms include difficult urination, sudden urges to urinate and inability to empty the bladder. BPH often is treated with medication and in severe cases open surgery may be necessary, but since 1997 transurethral microwave therapy has been a less-invasive option.

Transurethral microwave therapy involves using a catheter to place a microwave device within the prostate, which is then heated to destroy excess tissue. Approximately 70,000 such procedures are performed each year, usually in an office setting and typically involving patients from 50 to 85 years old.

This patient population is at high risk of cardiovascular disease, explains Benjamin Larson, a medical student at Cleveland Clinic who is the lead author of the Mayo Clinic Proceedings paper. Anecdotal reports of adverse blood pressure events during and after transurethral microwave therapy, and our own experience, led us to look back at the records to identi
'/>"/>

Contact: Joel Streed
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Page: 1 2

Related medicine news :

1. MedWaves, Inc. Announces Receipt of United States Food and Drug Administration 510k Clearance to Market Its Patented Microwave Coagulation/Ablation System
2. ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies
3. ELLE Eco-Salon & Spa Rolls Thru Southern California Offering Styling, Mini- Makeovers and Beauty Treatments
4. Identification of dopamine mother cells could lead to future Parkinsons treatments
5. Enzyme complex could be key to new cancer treatments
6. Women Can Now Learn About Minimally Invasive Gynecologic Treatments at AAGL.org
7. Many Women Unclear About Breast Cancer Treatments
8. Cancer treatments in phase 3 trials successful up to half of the time
9. Molecular biology of sleep apnea could lead to new treatments
10. Varian Announces Global Clinical Council to Develop RapidArc(TM) Cancer Treatments
11. Arizona Senate Approves Smoking Cessation Treatments for State Medicaid Beneficiaries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...rter financial results -, LAVAL, QC, July 25 /PRN...DAQ: DDSS) today announced that it will host a con... to discuss its second quarter 2008,financial resu... financial,results via news release at approximate...nce call by telephone, dial 416-646-3095 or,1-800-...
(Date:7/25/2008)...erweight or obese is not only a personal issue tha... issue that impacts other people in society. A new...eveals that the extra Medicare cost associated wit...ant financial burden on tax payers, costing up to ...current Medicare population. , The article,s fi...
(Date:7/25/2008)...Fourth Annual Physician On-Call Pay ...swire/ -- Sullivan, Cotter and Associates, Inc.,ha...on-call pay rates and,practices, the 2008 Physicia...th data from 132 healthcare organizations nationwi...ates paid for 33 physician specialty areas along,w...
(Date:7/25/2008)...ire/ -- Sagent Pharmaceuticals, Inc.,a privately-...nced that it,has launched amiodarone HCl injection...e treatment and prophylaxis of frequently recurrin...table ventricular,tachycardia -- a potentially lif...arone HCl injection will be available immediately ...
Breaking Medicine News(10 mins):Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3
...imed in treating AIDS patients using a herbal conc...se in white blood cell count. // Dr P L Meenakshi... reporters that the Herbal medicine helped HIV pa...(lymphocyte 4 - white blood cell) count increased ...
...lous kitten, when it comes to protecting her hands...f young ladies who drape themselves all over the r...at she would rather quit singing forever than lose...she gets really annoyed when girls flirt with her ...
...ded a grant of $30,000 to Medical College of Georg...understand the usefulness of online information sy...hether an online information system woulc be helpu...G was among 60 institutions invited to apply and t...
...essor and director of research in Virginia Commonw...ne reported that it will be fruitful // and more l...oving the medical facilities and provided the exis...ress allocates funds to the National Institute of ...
Other Medicine News:Health News:Online information system for patients 2Health News:Stop spending on new treatments; allocate funds to improve the existing treatments. 2
(Date:7/23/2008)... WASHINGTON, July 23 /PRNewswire-USNewswire/ --... of Justice:, Chairman Conyers, Ranking Member Sm...he opportunity to testify today., Since I appeare...ave,become even better acquainted with the talente...tment and with the work they do, and I have come t...
(Date:7/23/2008)... ASPS Study Finds Some Areas of the Body Have G...IGHTS, Ill., July 23 /PRNewswire-USNewswire/ -- Fa...hrough liposuction was found to be,an excellent so...ations,than other areas of the body, reports a Bra...ructive Surgery(R), the official medical journal o...
(Date:7/23/2008)... SEATTLE, July 23 /- Den... that it expects the Independent Data,Monitoring C...rim analysis,of overall survival relating to the C...e AdenoCarcinoma Treatment, also known as D9902B) ...ENGE is the Company,s investigational,active cellu...
(Date:7/22/2008)... BRISBANE, Australia, July 22 /PRNewswire-First...d late yesterday, the Board of Progen,Pharmaceutic...ed that it,had discontinued the PI-88 phase 3 stud...direction to develop its existing portfolio of com...re additional compounds and,opportunities through ...
Breaking Medicine Technology:Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Looking at neurons from all sides 3069 1Looking at neurons from all sides 3069 2deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor Positive Breast Cancer 4893 1deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor Positive Breast Cancer 4893 2deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor Positive Breast Cancer 4893 3deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor Positive Breast Cancer 4893 4deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor Positive Breast Cancer 4893 5Therap Services to Host Conference in Association with the Delaware Division of Developmental Disabilities Services 17817 1Therap Services to Host Conference in Association with the Delaware Division of Developmental Disabilities Services 17817 2Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment Naive Hepatitis C Patients Presented At EASL 1901 1Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment Naive Hepatitis C Patients Presented At EASL 1901 2Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment Naive Hepatitis C Patients Presented At EASL 1901 3Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment Naive Hepatitis C Patients Presented At EASL 1901 4Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment Naive Hepatitis C Patients Presented At EASL 1901 5Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment Naive Hepatitis C Patients Presented At EASL 1901 6Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment Naive Hepatitis C Patients Presented At EASL 1901 7Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment Naive Hepatitis C Patients Presented At EASL 1901 8Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment Naive Hepatitis C Patients Presented At EASL 1901 9
...DNEY, Australia, March 14, 2007 /Xinhua-PRNewswire...day announced the results,from its Phase II trial ...lmonary Disease (COPD), a respiratory disease,affe...l was conducted in 79 diagnosed COPD patients at 1...he trial was to,determine if subjects that were po...
...pany anticipates second quarter BLA filing for C1-... 2007 /PRNewswire-FirstCall/ -- Lev,Pharmaceutical...m,its pivotal U.S. Phase III trial of C1-esterase ...ditary angioedema (HAE). In the,acute study, which...tor in Hereditary Angioedema Nanofiltration Genera...
Other Medicine Technology:Pharmaxis Reports Phase II Results for Aridol in COPD 2Pharmaxis Reports Phase II Results for Aridol in COPD 3Pharmaxis Reports Phase II Results for Aridol in COPD 4Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 2Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 3Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 4Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 5
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
Medicine Products: